Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Dermatology
•
Bullous/Blistering Skin Disorders
What treatments can be combined for the treatment of immune checkpoint inhibitor induced toxic epidermal necrolysis?
Related Questions
What are your preferred treatment options for recalcitrant pemphigus vulgaris?
Would you utilize rituximab or dupilumab for treatment resistant bullous pemphigoid?
What is your stepwise approach to a patient with erosive gingivitis?
How often do you check desmoglien antibodies in pemphigus patients after treatment and during remission?
What is your approach to management of radiation-induced bullous pemphigoid?
What is your workup and management for patients with reactive perforating collagenosis?
How often have you found patients complain about an infusion reaction to Remicade?
What is your approach to diagnosis and treatment to intermittent cheilitis that does not respond to anti fungal therapy?
How have you employed AI-based tools in your practice and what do you foresee its role becoming?
What is your approach to patients with non-specific inflammatory reaction patterns in the skin (eg granulomatous)?
